Tuesday ” 14″ Sep 2021″XIGASHO: REUTERS
Xarun soo saarta tallaalka Moderna oo ay taageerto WHO ayay qarka u saaran tahay in ay hesho
Sarkaalka WHO ayaa sheegay in wadahadaladii hakad galay ee xarunta wareejinta teknolojiyadda iyo shirkad Mareykan ah ay hoos u dhigi karto mashruuca si loo soo saaro tallaalada Afrika.
Dadaallada lagu horumarinayo saldhig Afrikaan ah oo loogu talagalay soo-saarka tallaalka COVID-19 ayaa diiradda lagu saari doonaa isku dayga ku-dayashada tallaalka Moderna, laakiin horumar la’aanta wada-xaajoodyada lala galay shirkadda Mareykanka ayaa la micno ah in mashruucu qaadan doono waqti, sida uu sheegay sarkaal sare oo ka tirsan Ururka Caafimaadka Adduunka (WHO). .
Xayeeysiis
Wadada lagu soo saarayo talaalada Afrika waxaa loogu talagalay inay ka caawiso dalal badan oo soo koraya helitaanka marinnada COVID-19 kadib markii waddammada hodanka ah ay iibsadeen inta badan sahayda sanadkan
WHO: Tallaalka COVID-19 ayaa saddex laab ku noqda Afrika laakiin weli hooseeya
Moderna wuxuu yiri bishii Oktoobar ee la soo dhaafay ma dhaqan gelin doonto shatiyada la xiriira tallaalkeeda inta lagu jiro masiibada, taasoo kor u qaadeysa rajooyinka laga qabo in shirkadaha kale ay awoodaan inay koobi ka sameeyaan oo gacan ka geystaan kor u qaadista wax soo saarka tallaalka COVID-19.
Ficil ahaan, in kastoo, ay adag tahay in dib loo soo celiyo tallaal iyada oo aan la helin macluumaadka ku saabsan sida loo sameeyay, iyo xarunta gudbinta teknolojiyadda ee ay taageerto WHO ee Koonfur Afrika-oo la aasaasay bishii Juun si loo siiyo waddamada saboolka ah aqoonta ay u leeyihiin inay soo saaraan COVID-19 tallaalada – weli heshiis lama gaarin shirkadda.
Ial Fiidiyowyo ay ku dheggan yihiin dhejiska, ‘COVID-19 / Tallaalka Coronavirus / Cirbadda kaliya’ iyo sirinj caafimaad ayaa lagu arkay horteeda astaanta Moderna ee la soo bandhigay, Oktoobar 31, 2020
“Wadahadalladu ma keenin wax natiijo ah,” Martin Friede, oo ah Isuduwaha Cilmi -baarista Tallaalka WHO, ayaa u sheegay Reuters.
Moderna kama jawaabin codsiga WHO
Kiisku wuxuu iftiiminayaa caqabadaha soo wajahay WHO iyada oo u dagaallameysa ballaarinta wax soo saarka tallaalka si ay gacan uga geysato wax ka qabashada sinnaan -darrooyinka muuqda ee u dhexeeya waddamada hodanka ah iyo kuwa saboolka ah ee masiibada.
In ka badan saddex-meeloodow meel 5.5 bilyan oo ah COVID-19 tallaallada laga maamulo adduunka oo dhan ayaa aaday waddamada dakhligoodu sarreeyo iyo kuwa dhexe, kuwaas oo ka badan saddex meelood meel dadka adduunka.
Waqtigan xaadirka ah, kaliya 3 boqolkiiba Afrika ayaa la tallaaley, sarkaalka ugu sarreeya caafimaadka Midowga Afrika ayaa sheegay usbuucii hore, marka la barbar dhigo in ka badan kala bar Mareykanka iyo saddex meelood meel Spain.
Friede wuxuu sheegay in tallaalka Moderna la doortay sababta oo ah xog badan oo dadweyne iyo ballanqaadkeedii ahaa inaan la dhaqan gelin doonin shatiyada ayaa tallaalka wax yar ka fududeeyay nuqul ka badan kuwa la tartamaya.
“Waa inaan hadda doorannaa. Wakhtiga kama dambaysta ah ayaa ina saaran; wakhti aad ku bilowdo dalbashada kiimikooyinka. Waxaan doorannay Moderna, ”ayuu yidhi.
Laakiin xitaa haddii xarunta ay maamusho iyada oo aan la helin caawimaadda Moderna, waxay qaadan kartaa in ka badan hal sano si loo helo tallaal la qaybin karo maadaama tijaabooyinka caafimaadku ay bilaaban doonaan oo keliya qeybtii dambe ee 2022, ayuu raaciyay.
Bishii Maajo, Mareykanku wuxuu sheegay inay taageeri doonaan ka-dhaafitaanka xuquuqda lahaanshaha caqliga ee tallaallada COVID-19 si gacan looga geysto soo afjaridda masiibada.
Laakiin fikradda ayaa la kulantay diidmo ka timid shirkadaha dawooyinka, kuwaas oo ku doodaya inay u baahan yihiin inay kormeeraan wareejin kasta oo teknoloji ah sababtoo ah kakanaanta geedi -socodka wax -soo -saarka.
Pfizer iyo la-hawlgalaha BioNTech waxay si gooni gooni ah heshiis ugu gaareen Biovac-ka Koonfur Afrika si ay gacan uga geystaan sameynta qiyaastii 100 milyan oo tallaal sannad walba tallaalkooda COVID-19 ee Afrika. Toogashadoodu, sida tan Moderna, waxay adeegsataa waxa loogu yeero tikniyoolajiyadda mRNA.
Si kastaba ha ahaatee, heshiiska ayaa ah in “la buuxiyo oo la dhammeeyo” tallaalka, heerarka ugu dambeeya ee wax soo saarka halkaas oo alaabta lagu rido fijaan, la shaabadeeyo oo la xirxiro si loo dhoofiyo. Ma daboolayo geedi socodka murugsan ee soosaarka mRNA, kaas oo Pfizer iyo BioNTech ay ku samayn doonaan dhirtahooda Yurub.
WHO waxay isku dayaysay inay ka dhaadhiciso Moderna iyo Pfizer-BioNTech inay ku biiraan shirkadaha u gudbi kara Afrika.aqoonta soo saarista talaalad Covid 19
Laakiin kuwa sameeya tallaalka COVID-19 ayaa ka digay in soo-saareyaasha aan ruqsadda haysan ay u tartami doonaan alaabta ceeriin ee muhiimka ah iyo qalabka wax-soo-saarka ee ciyaartoydii la aasaasay-kuwaas oo intooda badan ka kasbaday faa’iidooyin badan tallaalka-ay ku tiirsan yihiin.
Shuraakada iskaashatada Hub ee Afrigen Biologics ayaa soo saari doonta dufcadii ugu horreysay ee qiyaaso, ka hor inta aysan xirfadaha iyo farsamada u wareejin lamaanaha wax-soo-saarka maxalliga ah, Machadka Biovac-labaduba waxay ku salaysan yihiin Cape Town-kuwaas oo soo saari doona tallaallada.
“Tani ma aha wax aan weyddiisanayno warshadaha inay na siiyaan lacag la’aan,” ayuu yiri Friede oo ku saabsan wadahadallada lala yeelanayo shirkadaha si loo helo xog, isagoo raaciyay in xuquuqda boqortooyada, xaddidaadda dhuleed iyo caqabadaha kale lagu dhisi karo heshiis.
Falanqeeyayaasha daryeelka caafimaadku waxay ka shakiyeen in qorshaha si dhaqso ah loo abaabuli karo.
Prashant Yadav, oo ah khabiir silsiladda sahayda daryeelka caafimaadka ee Xarunta Horumarinta Caalamiga ah ee Washington ayaa tiri: “Waxaa jira tallaabooyin badan oo u baahan doona soo noqnoqosho badan ka hor inta aysan diyaar u noqon wax soo saarka heerka-ganacsi ee ugu wanaagsan.”
XIGASHO: REUTERS
